首页> 外文期刊>International journal of infectious diseases : >High-risk human papillomavirus cervical infections among healthy women in Guadeloupe
【24h】

High-risk human papillomavirus cervical infections among healthy women in Guadeloupe

机译:瓜德罗普岛健康妇女中高危的人乳头瘤病毒宫颈感染

获取原文
           

摘要

Objective: To assess high-risk human papillomavirus (HR HPV) cervical infections and their type distribution among healthy women in Guadeloupe, French West Indies. Methods: The details of consecutive non-pregnant women who attended cervical cancer screening and had HPV genotyping performed at the largest pathology laboratory on the island from January 1, 2013 to December 31, 2014 were recorded retrospectively. All women with available HPV genotyping results were included in the study. Results: HR HPV genotyping results for 618 women (median age 42 years) were collected. The overall prevalence rate of HR HPV cervical infection was 36.1% (95% confidence interval (CI) 32.3-40.0%), with the following type distribution: HPV 16 or 18 irrespective of other HPV types, 7.3% (95% CI 5.4-9.6%); other HR HPV types excluding HPV 16 or 18, 28.8% (95% CI 25.3-32.5%). The prevalence rates of overall HR HPV and HR HPV other than 16 or 18 infection increased significantly (p<0.001) with the severity of cytology grade, from 19.7% for normal cytology to 53.8% in atypical squamous cells of undetermined significance (ASC-US) and 67.7% in low-grade squamous intraepithelial lesions (LSIL). Conclusion: The high prevalence rate of HR HPV cervical infection with genotypes other than 16 and 18 in Guadeloupe, irrespective of age and the cytology grade, suggests a potential benefit of the new nine-valent HPV vaccine to prevent HPV infection-related cancers in this Caribbean country.
机译:目的:评估法属西印度群岛瓜德罗普岛健康女性的高危型人乳头瘤病毒(HR HPV)宫颈感染及其类型分布。方法:回顾性记录2013年1月1日至2014年12月在岛上最大的病理实验室进行宫颈癌筛查并进行HPV基因分型的连续非妊娠妇女的详细信息。所有具有可用HPV基因分型结果的妇女均纳入研究。结果:收集了618名女性(中位年龄42岁)的HR HPV基因分型结果。 HR HPV宫颈感染的总体患病率为36.1%(95%置信区间(CI)32.3-40.0%),其类型分布如下:HPV 16或18,与其他HPV类型无关,为7.3%(95%CI 5.4- 9.6%);其他HP HPV类型(不包括HPV 16或18)为28.8%(95%CI 25.3-32.5%)。随着细胞学等级的严重程度,总体HR HPV和16或18感染以外的HR HPV的患病率显着增加(p <0.001),从正常细胞学的19.7%上升到不确定的非典型鳞状细胞的53.8%(ASC-US )和67.7%的低度鳞状上皮内病变(LSIL)。结论:无论年龄和细胞学等级如何,瓜德罗普岛16型和18型基因型HR HPV宫颈感染的高发生率,无论其年龄和细胞学等级如何,都表明这种新的9价HPV疫苗在预防HPV感染相关癌症方面具有潜在的优势。加勒比国家。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号